Microbiome-derived signals
Evidence level: review-abstract-only; unverified
Named in the review abstract as a candidate biomarker (signals derived from the microbial community of the airway). Unverified beyond the abstract.
As of . Primary source: Burman et al. 2026, J Heart Lung Transplant (DOI; abstract only was read).
Summary
The abstract of the review by Burman and colleagues names this candidate biomarker (signals derived from the microbial community of the airway). The abstract states that the biomarkers named may aid risk stratification, patient enrichment and endotype-guided trials. No performance data are stated, and this record is a stub that is unverified beyond the abstract. Only the abstract of the source review was read; the full text was not read.
Sources and links
Related
Links from this record
- named in (abstract only): CLAD: translating basic science to clinical practice
- candidate for endotype-guided use: Molecular endotypes of CLAD (proposed framework)
Linked from (derived)
- related to: Bronchoalveolar lavage: cell counts, microbiology and protein markers
- related to: Airway Microbiota Determines Innate Cell Inflammatory or Tissue Remodeling Profiles in Lung Transplantation
- evidence for: Lung microbiome quantification and bacterial density as prognostic markers in lung transplantation
- affects: CLAD is recognised late and no biomarker is validated for early warning
Known gaps in this record
- full text of the source review not read, so the evidence, citations and level of agreement for this item are missing
- funding and conflicts of interest of the source review not read
- assay, performance and validation status not recorded
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.